Starboard's stake comes amid a time of struggle at the drugmaker, which has begun to cut costs aggressively as demand for its Covid-19 medicines recedes.
Read Also
- China says two citizens killed, one injured, in Pakistan ‘terrorist attack’
- Harris, Trump step up attacks with less than a month to US presidential election
- 7 October, one year on: a return to kibbutz Nir Oz – podcast
- ‘A year is just too long’: relatives of Gaza hostages speak of their anguish
- How I built a $2 billion a year super app called Grab: '20 hour' work days
- US lawmakers arrive in Taiwan for bilateral talks amid China tensions
- Kamala Harris hits back at ‘childless’ attacks on Call Her Daddy podcast: ‘This is not the 1950s anymore’
- Iran’s chief of overseas arms dealings radio silent since Beirut strikes: Iranian officials
- 🔴 Live: Israel strikes Gaza and southern Beirut as attacks intensify
- Putin's 'Merchant of Death' Is Back in the Arms Business. This Time Selling to the Houthis.
Latest CNBC
- How I built a $2 billion a year super app called Grab: '20 hour' work days
- Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
- Mining giant Rio Tinto in talks to buy U.S. lithium producer Arcadium
- Asia-Pacific markets mostly set to climb ahead of a week of central bank decisions
- From guns to Trump: See which factors are deterring travelers from visiting the U.S.
- 'Joker: Folie a Deux' snares $40 million in domestic debut, less than half of first film
- Does your kid have a hard time making friends? There is a right way to help them, expert says: 'A lot of parents go too far'
- Harris floods the zone with Howard Stern, Stephen Colbert, podcast interviews in final election sprint
- Hollywood's franchise frenzy: More than half of top studios' 2025 movies are existing IP
- Trump holds Pennsylvania rally at same venue of first assassination attempt, joined by Musk, Vance